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SUMMARY 
Serum cholesterol, total triglycerides, HDL-cholesterol, LDL-cholesterol, VLDL-cholesteroI, free 
cholesterol and total phospholipids were studied in 36 patients of anxiety neurosis and 24 control subjects. 
Serum triglycerides, VLDL-cholesterol and free-cholesterol were found to be significantly r.iiscd while esteri-
fied cholesterol WJS sigiifiontly lowered in anxiety neurosis. A significant negative correlation was obser-
ved between the anxiety score and free cholesterol in ferrule patients. The significance of these findings has 
been discussed. 
Lipoprotein metabolism has gained 
profound importance ever since Miller 
and Miller (1975) reported the protec-
tive role of HDL cholesterol in the deve-
lopment of coronary heart disease (GHD). 
A number of recent investigations em-
phasize the relation of total cholesterol., 
total glycerides along with LDL choles-
terol and VLDL cholesterol with CHD 
HDL cholesterol showing an inverse re-
lation with the development of CHD is 
considered a major risk factor (Miller 
and Miller, 1975). More recently at-
tention has been drawn to the apoprotein 
(carrier ) rather than the lipid (carrier) 
component of serum lipoproteins, and 
the ratios of different lipoprotein are 
considered more sensitive indicators of 
atherogenesis than absolute values. 
A number of studies provide consi-
derable evidence for the role of anxiety 
and related emotional reactions in the 
development of CHD, seemingly more 
for angina pectoris than for MI (Jen-
kins, 1976). Although there is much 
work on lipid metabolism in cardiovas-
cular disorders, It has been comple-
tely ignored in various stress conditions. 
The present study was therefore under-
taken to study the lipid pro-file of pa-
tients of anxiety neurosis. 
METHOD 
Thirty six patients of anxiety neuro-
sis diagnosed as per Feighner's Diagnos-
tic Criteria (Feighner et al., 1972) at-
tending the out-patient Department of 
Psychiatry of the University Hospital 
(Banaras Hindu University, Vararasi) 
formed the sample of the present study. 
Patients who had been taking drugs du-
ring the past week or with concurrent 
physical illness were excluded. Each 
patient was subjected to a detailed eva-
luation: history of the present illness, 
past and family history of psychiatric 
illness and physical illnesses (diabetes, 
hypertension, CHD, renal diseases, 
thyrotoxicosis etc.), and personal history 
were recorded on a structured proforma. 
Apart from other details, personal his-
tory also included details of deitary ha-
bits, physical activity, smoking and al-
cohol intake. A physical examination 
and detailed mental status examination 
was done. Hamilton anxiety scale (Ha-
milton, 1969) was applied to measure 
the intensity of symptoms. 
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Twenty four control subjects were 
selected from the students and emplo-
yees of Institute of Medical Sciences, 
B. H. U. without evidence of any neuro-
psychiatry or physical illness. Both pa-
tients and control were subjected to rou-
tine investigations to exclude any he-
patic disorder, renal disease or diabetes 
mellitus. 
About 6 ml of blood was collected 
after overnight fasting for 12 hours in 
the morning. Serum was stored at 0°C-
4°C. All the analyses were done within 
two days of obtaining blood. Total cho-
lesterol was determined by the method of 
Bowman and Wolf (1962) and free cho-
lesterol was estimated by modification 
of Bowman and Wolf method (Bowman 
and Wolf (1962). The latter was sub-
tracted from the former to get the esteri-
fied cholesterol fraction. Serum trigly-
cerides were estimated by the method of 
Mendez el al. (1975). HDL cholestetol 
was determined after precipitation by 
phosphotungstate and magneisum chl-
oride (Burstein etal., 1910). Then by 
applying the formula of Friedwald et al. 
(1972), LDL-cholesterol was determined. 
RESULTS 
1. Sample characteristics: 
Anxiety neurosis patients were divi-
ded into different subgroups according 
to the Hamilton anxiety score. Nine-
teen patients were rated mild (score< 
13) whereas rest seventeen belonged to 
the moderate group (score between 13 
& 24). However there was no case of 
severe anxiety (score>25). Eight pa-
tients of mild anxiety, seven of moderate 
group and six of the control subjects 
belonged to female sex. The age group 
distributions of the patients as well as 
controls is given in table I. 
2. Lipid profile of control group ( Table II): 
Total cholesterol concentration was 
found to be in the range of 145-254 
TABLE I. Distribution of cases and con-
trol subject in different age groups 
Age in years Control group Anxiety neurosis 
N % N % 
10—29 10 41.7 19 52.8 
30—49 10 41.7 17 47.2 
50 or above 4 16.6 — — 
mg/dl. The mean triglyceride concen-
tration was 90.16±25.45.mg/dl. These 
values were comparable to the published 
reports from India (Bhattacharjee et al.} 
1978; Barrington et al., 1980; Gandhi, 
1982). Mean serum HDL cholesterol 
concentration was 47.80 ±7.74 mg/dl 
ranging from 40.9 to 58.8 mg/dl except 
one male having 38.3 mg/dl and one 
female having 69.0 mg/dl. In general 
females were found to have higher 
HDL cholesterol level in comparison 
to males. The LDL-cholesterol (LDLC) 
ranged between 67.4-177.4 mg/dl. The 
mean serum VLDL-cholesterol was 17. 
99±5.08mg/dl and the range was from 
12.7 to 26.6 mg/dl. 
Mean serum free cholesterol level 
was 54.25±12.96 mg/dl and that of 
esterified cholesterol was 135.53 ±26.65 
mg/dl, quite within the normal range of 
70-80% of esterification of cholesterol. 
3. Lipid changes in Anxiety Neurosis 
(Table -II): 
The mean serum total cholesterol 
concentration (of both subgroups) in 
anxiety neurosis did not show any signi-
ficant difference whereas their total 
glycerides showed highly significant in-
crease with respect to controls. Simi-
larly mean seium HDL cholesterol and 
LDL cholesterol concentration of anxiety 
neurosis/neurotics did not show any 
change whereas there was marked in-
crease in their VLDL concentration. SERUM LIPIDS IN ANXIETY NEUROSIS 
TABLE-II. Lipid profile in control and anxiety neurosis patients. 
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Control 
(N=24) 
Mild anxiety 
neurosis @ (1—12) 
(N=19) 
Moderate anxiety 
neurosis @ (13—24) 
(N=17) 
*P<0.05; 
@Himilton 
Mean 
SD. 
Mean 
SD. 
Mean 
SD. 
**p<0.01 
Tc 
mg/dl 
189.78 
30.63 
181.80 
32.02 
178.83 
31.18 
Tg 
mg/dl 
90.16 
25.45 
127.42*** 
36.95 
123.96 
34.04 
; ***p<0.001 
Anxiety Score. 
HDLC 
mg/dl 
47.80 
7.74 
47.08 
9.98 
45.81 
6.26 
LDLC 
mg/dl 
123.98 
0.87 
108.92 
31.18 
108.22 
30.66 
VLDLC 
mg/dl 
17.99 
5.08 
25.92*** 
7.39 
Fc 
mg/dl 
54.25 
12.96 
64.88* 
18.36 
24.78*** 56.13 
6.87  15.21 
E0 
mg/dl 
135.53 
26.65 
112.50** 
27.45 
119.75* 
22.84 
Free cholesterol was high only in mild 
anxiety neurosis patients while esteri-
fied fraction showed significant decrease, 
both in mild and moderate anxiety neu-
rosis. The ratios of HDL cholesterol to 
total cholesterol ar.d HDL cholesterol 
to LDL cholesterol did not show any 
significant change in comparison to con-
trols. 
4. Correlation of anxiety scores (in-
dicating degree of stress) with the diffe-
rent lipid parameters was studied by 
drawing regression line. No signifi-
cant correlation was found with any of 
the parameters. However, when male 
and female groups were separated, 
though no correlation was obtained in 
male patients, significant decrease in 
free cholesterol with increasing degree of 
anxiety score as measured by the ha-
milton Anxiety Scale was seen in female 
patients of anxiety neurosis (r=0.678). 
DISCUSSION 
In the present study the mean level 
of total cholesterol did not show any 
change but there was significant rise of 
total glycerides in both mild and moder-
ate anxiety neurotics. The rise in gly-
cerides may be due to increased activa-
tion of autonomic nervous system both 
in acute as well as in mild and prolonged, 
emotionally induced stress situations. 
During stress there is release of adre-
nocorticotrophic hormone (ACTH) and 
corticosteroids along with discharge of 
catecholamines which are known for 
their lipolytic action. Circulating cor-
ticosteroids suppress the availability of 
glucose in adipose tissue by antagoni-
sing the action of insulin. Thereby the 
lipolytic activity predominates in adi-
pose tissue leading to increase in circula-
ting free fatty acids, which get esterified 
to triglycerides in tissues like liver due 
to the presence of the enzyme glycero-
kinase. Similar increase in triglyceri-
des has been observed by other workers 
in different stress conditions (Wolf et al., 
1962; Taggart and Carruthers, 1971). 
Wolf et al. (1962) found high risk in 
triglycerides and total cholesterol in 
people exposed to difficulties in family 
or job including stressful interviews, 
whereas Taggart and Carruthers (1971) 
observed increase in triglycerides level 
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in racing drivers. In the latter case 
stress was more of acute and transitory 
type whereas our patients had a pro-
longed continuous stress of varying de-
grees. 
High level of serum triglycerides 
has been reported in coronary heart 
disease (CHD) (Dutt, 1967; Bhattachar-
jee eta/., 1978; KauKola et al., 1980). 
It has been shown that hypertriglyceri-
demia is more frequently associated with 
atherosclerotic cardiovascular disease 
than hypercholesterolemia (Carlson, 
1960; Hayes and Neil, 1964; Carlson 
and Bottiger, 1972; Rhoads et al., 1976) 
and also acts as an independent signifi-
cant major risk factor for coronary heart 
disease. 
Significant increase in VLDL cho-
esterol concentration was in patients of 
anxiety neurosis. It is well reported 
that plasma VLDL is atherogenic (Gold-
stein and Brown, 1977) and hyper 
VLDL-cholesterolemia has been reported 
by different workers in ischaemic heart 
disease (Vergani et al., 1978; Barrington 
et al., 1980) 
In the present study a significant 
risk in free cholesterol in mildly anxious 
patients and more significant reduction 
in esterified cholesterol was noted, where-
as moderate anxiety neurotics had only 
a significant reduction in esterified cho-
lesterol fraction The underlying me-
chanism is difficult to explain. To know 
the cause of decreased esterification the 
activity of serum lecithin cholesterol 
acyl transferase (LCAT), the major 
cholesterol esterifying enzyme, should 
be determined. 
No significant correlation was obser-
ved between the different lipid para-
meters studied and anxiety score from 
Hamilton anxity scale. This may be 
due to the fact that no single scale is ideal 
for measuring stress of a person and 
all scales available, to date, tap trait 
anxiety in addition to symptoms of an-
xiety. Among female patients however, 
a definite negative correlation of free 
cholesterol with increase of anxiety score 
was obtained. 
In conclusion, patients of anxiety 
neurosis showed hypertriglyceridemia 
and increased VLDL-cholesterol concen-
tration with reduction in esterified cho-
lesterol level. The first two changes 
favour the development of atherosclero-
tic process. 
The findings of the present work 
suggest that anxiety neurotics in the 
long run are at a greater risk for the 
development of atherosclerosis and its 
cardiovascular complications, and that 
triglycerides, VLDL cholesterol and 
esterified cholesterol are perhaps the 
biochemical variables mediating the 
cardiovascular psychosomatic response. 
These assumptions are however tentative 
ard further work is needed. 
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